These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1981157)

  • 1. The effect of neuroleptics on cognitive and psychomotor function.
    King DJ
    Br J Psychiatry; 1990 Dec; 157():799-811. PubMed ID: 1981157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the neuroleptic-induced deficit syndrome: clinical observations with remoxipride.
    Lewander T
    Acta Psychiatr Scand Suppl; 1994; 380():64-7. PubMed ID: 7914053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of risperidone on cognition in patients with schizophrenia.
    Stip E; Lussier I
    Can J Psychiatry; 1996 Oct; 41(8 Suppl 2):S35-40. PubMed ID: 8899249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychomotor impairment and cognitive disturbances induced by neuroleptics.
    King DJ
    Acta Psychiatr Scand Suppl; 1994; 380():53-8. PubMed ID: 7914050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE; Coyne L
    Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies.
    Goldberg TE; Weinberger DR
    J Clin Psychiatry; 1996; 57 Suppl 9():62-5. PubMed ID: 8823353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolerance of neuroleptics, deficit syndrome and cognitive functions].
    Kahn JP
    Encephale; 1996 Jun; 22 Spec No 2():49-54. PubMed ID: 8767043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.
    Lee MA; Jayathilake K; Meltzer HY
    Schizophr Res; 1999 May; 37(1):1-11. PubMed ID: 10227103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of late-life schizophrenia with neuroleptics.
    Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
    Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive performance of medicated schizophrenics with tardive dyskinesia.
    Collerton D; Fairbairn A; Britton P
    Psychol Med; 1985 May; 15(2):311-5. PubMed ID: 2862650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings.
    Finkelstein JR; Cannon TD; Gur RE; Gur RC; Moberg P
    J Abnorm Psychol; 1997 May; 106(2):203-12. PubMed ID: 9131840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clozapine on cognitive function in schizophrenia.
    Lee MA; Thompson PA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of activation procedures on neuroleptic-induced akathisia.
    Fleischhacker WW; Miller CH; Barnas C; Bergmann K; Perovich R; Alvir JM; Lieberman JA; Kane JM
    Br J Psychiatry; 1993 Dec; 163():781-4. PubMed ID: 7905775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cognitive efficacy of atypical antipsychotics in schizophrenia.
    Sharma T; Mockler D
    J Clin Psychopharmacol; 1998 Apr; 18(2 Suppl 1):12S-9S. PubMed ID: 9555611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond control of acute exacerbation: enhancing affective and cognitive outcomes.
    Meltzer HY
    CNS Spectr; 2003 Nov; 8(11 Suppl 2):16-8, 22. PubMed ID: 14978453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.
    Cassens G; Inglis AK; Appelbaum PS; Gutheil TG
    Schizophr Bull; 1990; 16(3):477-99. PubMed ID: 1981108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of schizophrenia. Overview of recent research.
    Marder SR; Wirshing WC; Van Putten T
    Schizophr Res; 1991; 4(2):81-90. PubMed ID: 1674883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.